Admission Date:  [**2164-3-12**]              Discharge Date:   [**2164-3-13**]  Date of Birth:  [**2099-3-2**]             Sex:   F  Service: MEDICINE  Allergies: Cephalexin / Augmentin / Lisinopril / Clindamycin / Morphine  Attending:[**First Name3 (LF) 17865**] Chief Complaint: Hypertension, Shortness of breath  Major Surgical or Invasive Procedure: None  History of Present Illness: 64F morbidly obese with past medical history significant for diabetes, CHF, and hypercarbic respiraotry failure who was transferred from Radius for respiratory distress.
The patient was given 80g IV lasix and nebs at Radius and put on a non-rebreather.
Pt arrived with Foley in place.
Pt had a Foley and PICC in place.
Sister, [**Name (NI) 81285**] is contact, [**Telephone/Fax (1) 81286**]  Family History: Mother - DM, HTN, HL Father - [**Name (NI) **] clots   Physical Exam: Vitals 97.6  67  141/47  19 94%on 3L Gen:  Morbidly obese female, NAD HEENT:  NC, AT, OP clear Neck:  Thick, unable to assess JVP Resp:  symmetric, clear but difficult to assess [**1-30**] body habitus CV:  RRR, difficult to assess, [**1-30**] body habitus ABD:  soft, NT, BS +, large pannus EXT:  Left BKA, right heel ulcer SKIN:  evidence of fungal infection under right breast - indurated with white, cottage cheese-like deposits   Pertinent Results: [**2164-3-12**] 03:50AM   WBC-9.4 RBC-3.57* HGB-9.1* HCT-30.8* MCV-86 MCH-25.3* MCHC-29.4* RDW-14.6 [**2164-3-12**] 03:50AM   NEUTS-78.8* LYMPHS-12.4* MONOS-3.3 EOS-5.4* BASOS-0.2 [**2164-3-12**] 03:50AM   PLT COUNT-173 [**2164-3-12**] 03:50AM   CK-MB-NotDone proBNP-1042* [**2164-3-12**] 03:50AM   ALT(SGPT)-13 AST(SGOT)-11 CK(CPK)-44 ALK PHOS-110 TOT BILI-0.4 [**2164-3-12**] 03:50AM   GLUCOSE-106* UREA N-65* CREAT-2.0* SODIUM-143 POTASSIUM-4.5 CHLORIDE-104 TOTAL CO2-34* ANION GAP-10 [**2164-3-12**] 03:55AM   HGB-9.7* calcHCT-29 O2 SAT-98 CARBOXYHB-2 MET HGB-0 [**2164-3-12**] 04:00AM URINE  [**Month/Day/Year 3143**]-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-TR [**2164-3-12**] 09:14AM   LACTATE-0.7 [**2164-3-12**] 05:40PM   CK-MB-3 cTropnT-0.06* [**2164-3-12**] 05:40PM   CK(CPK)-48 .
Suggestion of a nodular opacity in the RUL, could represent confluent edema, repeat imaging after diuresis to exclude an underlying pathology is recommended .
Patient was somewhat somnolent on nasal cannula.
Torsemide was held and patient was switched to 60mg lasix [**Hospital1 **].
Was put on bipap intermittently and would recommend continued use at night.
Continued nebs and asthma meds .
Continued Fe supplementation .
#  Hyperlipidemia - Continued statin .
#  Anti-coag - Patient on fondaparinux.
#  Right Heel Ulcer - Wound care per nursing.
Medications on Admission: Albuterol 0.083% Neb Soln 1 NEB IH Q6H Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Amlodipine 10 mg PO DAILY Lactulose 15 mL PO QID Aspirin 81 mg PO DAILY Montelukast Sodium 10 mg PO HS Citalopram Hydrobromide 40 mg PO DAILY Nephrocaps 1 CAP PO DAILY Docusate Sodium 100 mg PO BID Neomycin-Polymyxin-HC Otic Susp 4 DROP BOTH EARS TID Doxazosin 4 mg PO HS Omeprazole 40 mg PO DAILY Fexofenadine 60 mg PO BID Os-Cal 500 + D *NF* 500 (1,250)-200 mg-unit Oral daily Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **] Oxycodone-Acetaminophen [**12-30**] TAB PO Q6H Fluticasone Propionate NASAL 1 SPRY NU DAILY Fondaparinux Sodium 2.5 mg SC DAILY Senna 2 TAB PO HS Furosemide 60 mg PO DAILY Simvastatin 80 mg PO DAILY Torsemide 10 mg PO BID HydrALAzine 25 mg PO Q6H Valsartan 120 mg PO DAILY Hydrochlorothiazide 25 mg PO Q6H Insulin  Discharge Medications: 1.
B Complex-Vitamin C-Folic Acid 1 mg Capsule Sig: One (1) Cap PO DAILY (Daily).
Insulin Glargine 100 unit/mL Solution Sig: Twenty (20) units Subcutaneous once a day.
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours).
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q2H (every 2 hours) as needed.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q2H (every 2 hours) as needed.
Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO Q6H (every 6 hours).
Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation [**Hospital1 **] (2 times a day).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours).
Lactulose 10 gram/15 mL Syrup Sig: Fifteen (15) ML PO QID (4 times a day).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: 1-2 Tablets PO HS (at bedtime).
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Montelukast 10 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Fexofenadine 60 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) Spray Nasal DAILY (Daily).
Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Valsartan 40 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Simvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Doxazosin 4 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Neomycin-Polymyxin-HC 3.5-10,000-1 mg-unit/mL-% Drops, Suspension Sig: Four (4) Drop Otic TID (3 times a day).
Labetalol 200 mg Tablet Sig: Four (4) Tablet PO BID (2 times a day).
Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.
Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO DAILY (Daily).
Calcium Carbonate 500 mg (1,250 mg) Tablet Sig: 2.5 Tablets PO DAILY (Daily).
Hydralazine 50 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours).
Furosemide 20 mg Tablet Sig: Three (3) Tablet PO BID (2 times a day): continue for one ,more day and then decrease to daily.
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID (3 times a day).
Clonidine 0.1 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Discharge Disposition: Extended Care  Facility: [**Hospital3 672**] Hospital  Discharge Diagnosis: Chronic Obstructive Pulmonary Disease OSA and pulmonary HTN - uses BiPAP/CPAP at night, with 2L O2 requirement during the day Type I Diabetes with retinopathy, nephropathy, neuropathy Morbid Obesity Coronary Artery Disease Hypertension Chronic Kidney Disease   Discharge Condition: Improved  Discharge Instructions: You were admitted to the hospital for worsening shortness of breath and a low oxygen saturation.
You were treated with non-invasive ventilation and lasix and your breathing improved.
The dose of your lasix was increased to twice a day.
Please continue to take lasix twice a day for one more day than return to previous daily dose.
Please take all medications as prescribed and return to the hospital for any chest pain, worsening shortness of breath or any other symptoms that are new or of concern to you   Followup Instructions: Please follow-up as needed with your primary care provider.
